Delivery Order SPE2DB22D3102-SPE2DB25FK9YF

Award Date 2/12/25
Potential Completion Date 3/6/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,559.10 firm fixed-price delivery order is for XEOMIN 50 UNIT VIALS, with a completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $91,116.48 firm fixed-price delivery order is for the supply of 4,566,559,471 units of XEOMIN 200 UNIT VIALS. The contract has an ultimate completion date of December 18, 2024 and was awarded on November 26, 2024. This contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,237.00 firm fixed-price delivery order is for the supply of 200-unit vials of the drug XEOMIN. The contract has an ultimate completion date of September 17, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,484.80 firm-fixed-price delivery order is for the supply of 4,566,142,434 units of XEOMIN 100 UNIT VIALS, with a completion date of November 7, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,970.00 firm fixed-price delivery order contract is for the supply of XEOMIN 50 unit vials, with a period of performance through November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $2,793.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,093,142 units of XEOMIN 100 UNIT VIALS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of February 19, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,084.72 firm fixed-price delivery order is for the supply of 4,566,799,710 units of the drug XEOMIN, a medication used for various medical conditions. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, with a ceiling value of $1,396.85, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a delivery order, provides for the procurement of XEOMIN 100 UNIT VIALS. The contract has an ultimate completion date of February 6, 2025 and uses a firm-fixed-price pricing type. The award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $2,621.20 firm fixed price delivery order is for the supply of 4,565,314,604 units of the pharmaceutical product XEOMIN 100 UNIT VIALS. The contract has an ultimate completion date of August 21, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as part of the DLA Troop Support Medical's...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $13,106 for the supply of 4,566,202,222 vials of the medication XEOMIN. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. The contract is a firm fixed-price delivery order that runs through November 15, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB25FK9YF
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,409.76 firm fixed-price delivery order is for the supply of 4,567,271,658 units of the medication XEOMIN 200 UNIT VIALS. The contract has an ultimate completion date of March 6, 2025.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order appears to be a specific task order issued under that larger IDC contract. The contract award does not indicate any set-aside requirements, suggesting it was competitively awarded.

Generated 5/14/25, 10:29 AM